---
id: treatment-chemotherapy-further-reading-and-info
uri: treatment/chemotherapy/further-reading
title: Chemotherapy
type: further
updated_at: 2018-11-09T15:43:40Z
created_at: 2017-03-09T12:00:04Z
---

<h2>Textbooks</h2>
<p>C. Avendano and J.C. Menendez. Medicinal Chemistry of Anticancer
    Drugs. Elsevier, Amsterdam, 2<sup>nd</sup> edition, 2015.</p>
<aside>
    <p>Broad overview covering the properties of a large number
        of anticancer drugs; not all commonly used in the treatment
        of head and neck cancers.</p>
</aside>
<p>B.A. Chabner and D.L. Longo (eds.). Cancer Chemotherapy and Biotherapy:
    Principles and Practice. Wolters Kluwer, Aalphen, 5<sup>th</sup>    edition, 2010.</p>
<aside>
    <p>Up-to-date review-style in-depth information about current
        chemo- and biotherapy regimes, covering basic principles
        as well as aspects of clinical application.</p>
</aside>
<p>D.E.V. Wilman (ed). The chemistry of antitumour agents. Blackie,
    Glasgow and London, 1990.</p>
<aside>
    <p>Textbook describing chemical properties of (amongst others)
        platinum drugs, antifolates (MTX) and nucleoside analogues
        (5-FU).</p>
</aside>
<p>G. Powis and R.A. Prough (eds.). Metabolism and Action of Anti-Cancer
    Drugs. Taylor and Francis, London, 1987.</p>
<aside>
    <p>Old but extensive coverage of metabolic pathways of classical
        anti-cancer drugs, including 5-FU, MTX and platinum drugs.</p>
</aside>
<p>T. Priestmann. Cancer Chemotherapy in Clinical Practice. Springer
    Verlag, London, 2008.</p>
<aside>
    <p>Good and critical overview.</p>
</aside>
<p>R.T. Skeel and S.N. Khleif (eds.). Handbook of Cancer Chemotherapy.
    Wolters Kluwer, Philadelphia, 8<sup>th</sup> edition, 2011.</p>
<aside>
    <p>Handbook of clinical applications, including some head and
        neck malignancies.</p>
</aside>
<p>B. Anderson and D. Murray (eds.).Clinically Relevant Resistance
    in Cancer Chemotherapy. Kluwer Academic Publishers, Doordrecht,
    2002.</p>
<aside>
    <p>Good overview.</p>
</aside>
<p>M.C. Perry, D.C. Doll and C.E. Freter (eds.). The Chemotherapy
    Source Book. Wolters Kluwer, Philadelphia, 5<sup>th</sup>    edition, 2012.</p>
<aside>
    <p>Broad overview of clinical applications, including some head
        and neck malignancies.</p>
</aside>
<h2>Journal articles</h2>
<p>B. Rosenberg, L. Vankamp and T. Krigas. Inhibition of cell division
    in E. coli by electrolysis products from a platinum electrode.
    <i>Nature</i> <strong>205</strong>, 698-699 (1965).</p>
<aside>
    <p>The original paper about the accidental discovery of the
        cytotoxic properties of some platinum complexes.</p>
</aside>
<p>H. Umezawa, K. Umezawa, T. Maeda and T. Takeuchi Okami. New antibiotics,
    bleomycin A and B. <i>J. Antibiotics</i> <strong>19</strong>,
    200-209 (1966).</p>
<aside>
    <p>The original report about bleomycin as an antibiotic.</p>
</aside>
<p>L.G. Campana, B. Mali, G. Sersa, S. Valpione, C.A. Giorgi, P.
    Strojan, D. Miklavcic and C.R. Rossi. Electrochemotherapy
    in non-melanoma head and neck cancers: a retrospective analysis
    of the treated cases. <i>British Journal of Oral and Maxillofacial Surg</i>ery
    <strong>52</strong>, 937-964 (2014).</p>
<aside>
    <p>Review article covering role of bleomycin in electrochemotherapy.</p>
</aside>
<p>E.R. Jamieson and A.J. Lippard. Structure, recognition and processing
    of cisplatin-DNA adducts. <i>Chemical Reviews</i> <strong>99</strong>,
    2467-2498 (1999).</p>
<aside>
    <p>Review of mode of action of cisplatin.</p>
</aside>
<p>Z.H. Siddik. Cisplatin: mode of cytotoxic action and molecular
    basis of resistance. <i>Oncogene</i> <strong>22</strong>,
    7265-7279 (2003).</p>
<aside>
    <p>A thorough review of resistance mechanisms.</p>
</aside>
<p>I. Ott. On the medicinal chemistry of gold complexes as anticancer
    drugs. <i>Coordination Chemistry Revews</i>. <strong>253</strong>,
    1670-1681 (2009).</p>
<aside>
    <p>Ongoing research activities to find additional metal complexes
        with antineoplastic properties but less prone to develop
        resistance and with fewer and/or less severe side effects
        than the various platinum complexes show.</p>
</aside>
<p>S. Dasari, P.B. Tchounwou and P. Bernard. Cisplatin in cancer
    therapy: Molecular mechanisms of action. <i>European Journal  of Pharmacol</i>ogy
    <strong>749</strong>, 364-378 (2014).</p>
<aside>
    <p>Review article with extensive list of recent publications.</p>
</aside>
<p>M. Rebucci and C. Michiels. Molecular aspects of cancer cell
    resistance to chemotherapy. <i>Biochemical  Pharmacology</i>     <strong>85</strong>, 1219-1226 (2013).</p>
<aside>
    <p>A balanced and readable overview with some perspectives discussed,
        100 relevant references given.</p>
</aside>
<p>N. Normanno, A. de Luca, C. Bianco, L. Strizzi, M. Mancino, M.R.
    Maiello, A. Carotenuto, G. de Feo, F. Caponigro and D.S.
    Salomon. Epidermal growth factor receptor (EGFR) signalling
    in cancer. <i>Gene</i> <strong>366</strong>, 2-16 (2006).</p>
<aside>
    <p>Good general overview, not specific for head and neck malignancies.</p>
</aside>
<p>J. Fukai, K. Nishio, T. Hakura and F. Koizumi. Antitumor activity
    of cetuximab against malignant glioma cells overexpressing
    EGFR deletion mutant variant III. <i>Cancer Science</i> <strong>99</strong>,
    2062-2069 (2008).</p>
<aside>
    <p>Mechanism of cetuximab in inhibiting EGFR.</p>
</aside>
<p>J.E. Frampton. Cetuximab. A Review of its Use in Squamous Cell
    Carcinoma of the Head and Neck. <i>Drugs</i> <strong>70</strong>,
    1987-2010 (2010).</p>
<p>J. Capdevial, E. Elez, T. Macarulla, F.J. Ramos, M. Ruiz-Echarri
    and J. Tabernero. Anti-epidermal growth factor receptor monoclonal
    antibodies in cancer treatment. <i>Cancer Treatment Reviews</i>    <strong>35</strong>, 354-363 (2009).</p>
